GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (CHIX:NSISBc) » Definitions » Shiller PE Ratio

Novonesis (Novozymes) B (CHIX:NSISBC) Shiller PE Ratio : (As of Dec. 11, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Novonesis (Novozymes) B Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis (Novozymes) B Shiller PE Ratio Historical Data

The historical data trend for Novonesis (Novozymes) B's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Shiller PE Ratio Chart

Novonesis (Novozymes) B Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.82 38.38 54.32 31.02 31.73

Novonesis (Novozymes) B Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.32 27.65 24.29 31.73 -

Competitive Comparison of Novonesis (Novozymes) B's Shiller PE Ratio

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Shiller PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Shiller PE Ratio falls into.



Novonesis (Novozymes) B Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novonesis (Novozymes) B's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Novonesis (Novozymes) B's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0/118.5000*118.5000
=0.000

Current CPI (Jun. 2024) = 118.5000.

Novonesis (Novozymes) B Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 1.869 99.700 2.221
201409 2.030 99.700 2.413
201412 1.935 99.400 2.307
201503 2.268 100.200 2.682
201506 2.199 100.300 2.598
201509 2.409 100.200 2.849
201512 2.246 99.800 2.667
201603 2.432 100.200 2.876
201606 2.460 100.600 2.898
201609 2.479 100.200 2.932
201612 2.704 100.300 3.195
201703 2.580 101.200 3.021
201706 2.471 101.200 2.893
201709 2.770 101.800 3.224
201712 2.651 101.300 3.101
201803 2.726 101.700 3.176
201806 2.649 102.300 3.068
201809 2.757 102.400 3.190
201812 2.879 102.100 3.341
201903 2.407 102.900 2.772
201906 3.123 102.900 3.596
201909 2.230 102.900 2.568
201912 3.244 102.900 3.736
202003 2.883 103.300 3.307
202006 2.280 103.200 2.618
202009 2.527 103.500 2.893
202012 2.334 103.400 2.675
202103 3.150 104.300 3.579
202106 2.830 105.000 3.194
202109 3.011 105.800 3.372
202112 2.237 106.600 2.487
202203 2.980 109.900 3.213
202206 2.901 113.600 3.026
202209 4.143 116.400 4.218
202212 3.156 115.900 3.227
202303 2.818 117.300 2.847
202306 2.179 116.400 2.218
202309 3.363 117.400 3.395
202312 2.545 116.700 2.584
202406 0.000 118.500 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis (Novozymes) B  (CHIX:NSISBc) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novonesis (Novozymes) B Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines